"Life Sciences Leaders Act to Counter Insider-Driven Data Loss"

According to Code42, life sciences companies, such as medical device manufacturers, biotechnology companies, and pharmaceutical companies, are experiencing increased insider-caused data loss. With this expanding threat, life sciences leaders increasingly prioritize effective modern data loss prevention strategies. While data loss from insiders, or insider risk, occurs in all industries, it is especially damaging for life sciences companies as they contain large amounts of sensitive data, including patient information, product designs, formulations, trial results, and manufacturing details. Therefore, it is essential to protect sensitive data from unauthorized access in order to maintain a competitive advantage and guarantee uninterrupted business operations. Nearly 70 percent of respondents in the life sciences sector have observed an increase in data loss incidents caused by insiders over the past year, and they expect an even greater increase over the next 12 months. Seventy-eight percent of CISOs in the life sciences industry have a program dedicated to insider risk or threats, indicating that they recognize the issue's urgency. This article continues to discuss key findings regarding data exposure in the life sciences sector. 

Help Net Security reports "Life Sciences Leaders Act to Counter Insider-Driven Data Loss"

Submitted by Anonymous on